We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 75.00 | 73.00 | 77.00 | 75.00 | 75.00 | 75.00 | 12 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -3.43 | 10M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/10/2021 15:37 | Ged5 It is supposition yes and defending IP is actually a much worse scenario than just getting a decent sales foothold and reputation. | yump | |
11/10/2021 14:59 | Wincarnis all round Ged? Very popular in Jamaica I hear. They mix it with stout and milk. We should all meet up there in 12 months time. | lr2 | |
11/10/2021 14:53 | You know, Digger, when he mentioned 'watch this space' with a little chuckle, I just felt that he saw an earlier post where it was said 'we've been watching this space for two effing years'. Perhaps those commercial opportunities can soon be turned into contracts. Maybe your fortune is changing! | ged5 | |
11/10/2021 14:20 | Cheers Ged. Every little helps and more "spaces to watch"! Three of my slumbering doggies are in the top ten % gainers on ADVFN home page. Sadly they are all still underwater but moving in the right direction. Fingers crossed eh. | digger2779 | |
11/10/2021 12:57 | I have always loved the simple Bleepa concept and I still believe it has an exciting future ahead particularly as it aims to become a standard in the imaging area. | petekand | |
11/10/2021 12:45 | Well the market like it - India and Africa are big markets to service | ragnarr | |
11/10/2021 10:38 | 700k at .0843p. Not a massive amount but a few of these beginning to appear recently. Always good to hear your views, Yump. You seem to be experienced in business matters but isn't what you are saying supposition? I think we'd all like to see Bleepa adopted by the NHS. Could it be that success could come from India? | ged5 | |
11/10/2021 10:04 | At this point, I think the IP surrounding Bleepa becomes crucial. It may be that the developments within the NHS provide a moat of some sort and/or there is some really important IP, but when you release something like this worldwide, before you've established a market, it will get reverse-engineered. I hope this is not a naive error by FDBK, but there have been a lot of 'world-beating' products released into the wild before they've got much revenue in the UK and I don't recall any of them as good investments. If the steps by which Bleepa has been developed are just logical developments, there will be little chance of unique IP being possible. The defence against that is to establish very strong home market sales and your brand. | yump | |
11/10/2021 10:02 | Looks like we've gone to 5v1 | ged5 | |
11/10/2021 09:58 | That's OK, so long as there is a tomorrow. Slowly building a network of partners. What we need now is the whoosh! "The demand for diagnostic and image interpretation services in radiology is growing rapidly all over the world. According to a survey by Outsource 2india, with the increase in demand for imaging scans and the US facing about 20 percent short age of radiologists, the market for Teleradiology services has increased significantly in the past five years. This has helped India become the largest Teleradiology hub in the world with various companies mushrooming in Bangalore, Pune, Delhi,and other Indian cities.These companies offer Teleradiology services to hospitals/healthcare institutions in the US and other Middle Eastern and European countries. Quest Teleradiology Solutions is a Bangalore based company that provides complete radiology services extending from diagnostic business development to Tele reporting. The organization offers comprehensive radio diagnosis solutions to hospitals and diagnostic centers in India and across the world, promoted by a team of medical doctors and management professionals with a combined healthcare experience of over 90 years." | ged5 | |
11/10/2021 09:45 | Copious amounts of jam tomorrow. | ducatiman | |
10/10/2021 15:11 | Is it "funfest"? | orange1 | |
10/10/2021 00:14 | Its another word ;-) | yump | |
09/10/2021 20:45 | Don't think you can call him a fascist Yump, according to his dating profile he's a leftie. | lr2 | |
09/10/2021 15:49 | He’s here for a reason, my guess is he is hoping to pick up Texrad on the cheap. He’s just put £150k of his own cash into his company’s highly dilutive placing. I wonder if TO will be participating when it’s our turn? | ducatiman | |
09/10/2021 13:55 | How unfortunate for you yump; but Ged has been around for so many years that I regard him as a kind of friend, through sheer familiarity. He's been a member since 2003 and posted over 6000 times, mainly about Feedback | ydderf | |
09/10/2021 13:02 | 5 grand's worth of whistling Ged, the dawn will come one day, have another swig of Wincarnis my friend | ydderf | |
08/10/2021 19:18 | Indeed Ged, just waiting for Mr.predictable to tell us that for every buy there is a sell 😂. | ducatiman | |
08/10/2021 16:17 | Just over 700k at .727p. Not bad! | ged5 | |
08/10/2021 10:55 | UK paradigm exemplified by posts above. Mistreated faux optimistic (what alternative is there?) shareholder financial cannon fodder whistling bravely to each other in the face of appalling neglect and mistreatment, fatalistically accepted, while General O dines on steak and champers safely insulated from the front-line by his pay and rations....keep up the Blighty spirit lads, tomorrow belongs to you | ydderf | |
08/10/2021 06:23 | Great taste in music Ged. Hope you all use a pink envelope too. | ducatiman | |
07/10/2021 21:29 | Feedback shareholders hanging around waiting for something magnificent to appear. | lr2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions